Search company, investor...

3DMED Biomedical

Founded Year




Total Raised


Date of IPO


About 3DMED Biomedical

3DMED Biomedical, spun off from 3DMED, is a biomedical company engaged in the development and commercialization of a new generation of tumor immunotherapy drugs. The company was founded in 2015 and is based in Shanghai, China.

Headquarters Location

Building 11, No.118 Furonghua Road Pudong New Area

Shanghai, Shanghai,



Missing: 3DMED Biomedical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: 3DMED Biomedical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing 3DMED Biomedical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

3DMED Biomedical is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

3DMED Biomedical Frequently Asked Questions (FAQ)

  • When was 3DMED Biomedical founded?

    3DMED Biomedical was founded in 2015.

  • Where is 3DMED Biomedical's headquarters?

    3DMED Biomedical's headquarters is located at Building 11, No.118 Furonghua Road, Shanghai.

  • What is 3DMED Biomedical's latest funding round?

    3DMED Biomedical's latest funding round is IPO.

  • How much did 3DMED Biomedical raise?

    3DMED Biomedical raised a total of $144.88M.

  • Who are the investors of 3DMED Biomedical?

    Investors of 3DMED Biomedical include Ruixia Investment, Tigermed, EFung Capital, Adrian Cheng, China Capital Management and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.